AIP
ERAS icon

Ameritas Investment Partners’s Erasca ERAS Stock Holding History

Ameritas Investment Partners’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
18,166
+2,642
+17% +$37.8K 0.01% 1084
2026
Q1 		$251K Buy
15,524
+879
+6% +$10.4K 0.01% 1136
2025
Q4 		$54.5K Sell
14,645
-3,335
-19% -$9.38K ﹤0.01% 2063
2025
Q3 		$39.2K Hold
17,980
– – ﹤0.01% 2316
2025
Q2 		$22.8K Hold
17,980
– – ﹤0.01% 2599
2025
Q1 		$24.6K Hold
17,980
– – ﹤0.01% 2457
2024
Q4 		$45.1K Hold
17,980
– – ﹤0.01% 2247
2024
Q3 		$49.1K Buy
17,980
+6,930
+63% +$19.5K ﹤0.01% 2199
2024
Q2 		$26.1K Buy
11,050
+6,093
+123% +$13.1K ﹤0.01% 2500
2024
Q1 		$10.2K Hold
4,957
– – ﹤0.01% 2808
2023
Q4 		$10.6K Hold
4,957
– – ﹤0.01% 2830
2023
Q3 		$9.77K Hold
4,957
– – ﹤0.01% 2844
2023
Q2 		$13.7K Hold
4,957
– – ﹤0.01% 2770
2023
Q1 		$14.9K Hold
4,957
– – ﹤0.01% 2566
2022
Q4 		$19.3K Hold
4,957
– – ﹤0.01% 2584
2022
Q3 		$38K Hold
4,957
– – ﹤0.01% 2174
2022
Q2 		$27K Hold
4,957
– – ﹤0.01% 2383
2022
Q1 		$43K Buy
4,957
+3,372
+213% +$39.1K ﹤0.01% 2139
2021
Q4 		$25K Hold
1,585
– – ﹤0.01% 2534
2021
Q3 		$34K Buy
+1,585
New +$32.7K ﹤0.01% 2392

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Ameritas Investment Partners's ERAS Position: Q2 2026 in Review

Ameritas Investment Partners increased its Erasca (ERAS) stake by 17% in Q2 2026, buying an estimated $37.8K and bringing the position to 18,166 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #1084.

Ameritas Investment Partners first reported a position in ERAS in Q3 2021 and has held it in 20 quarters since. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Ameritas Investment Partners held 18,166 shares of Erasca worth $333K as of Q2 2026.
  • Ameritas Investment Partners bought 2,642 Erasca shares in Q2 2026, an estimated $37.8K.
  • Erasca made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1084 holding.
  • Ameritas Investment Partners first reported a position in Erasca in Q3 2021 and has held it in 20 quarters since.
  • 256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.